These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 35238067)

  • 1. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis.
    Wu JJ; Kavanaugh A; Lebwohl MG; Gniadecki R; Merola JF
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):797-806. PubMed ID: 35238067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.
    Puig L
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Place in therapy of anti-IL-17 and 23 in psoriasis according to the severity of comorbidities: a focus on cardiovascular disease and metabolic syndrome.
    Trovato E; Rubegni P; Prignano F
    Expert Opin Biol Ther; 2022 Dec; 22(12):1443-1448. PubMed ID: 35726639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Tildrakizumab on Cardiometabolic Risk Factors in Psoriasis by Metabolic Syndrome Status: Post Hoc Analysis of Two Phase 3 Trials (ReSURFACE 1 and ReSURFACE 2).
    Menter MA; Mehta NN; Lebwohl MG; Gottlieb AB; Mendelsohn AM; Rozzo SJ; Leonardi C
    J Drugs Dermatol; 2020 Aug; 19(8):703-708. PubMed ID: 32845115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasis and cardiovascular disorders.
    Frieder J; Ryan C
    G Ital Dermatol Venereol; 2016 Dec; 151(6):678-693. PubMed ID: 27627099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome in patients with psoriatic disease.
    Gelfand JM; Yeung H
    J Rheumatol Suppl; 2012 Jul; 89():24-8. PubMed ID: 22751586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome, C-reactive protein and cardiovascular risk in psoriasis patients: a cross-sectional study.
    Paschoal RS; Silva DA; Cardili RN; Souza CDS
    An Bras Dermatol; 2018 Mar; 93(2):222-228. PubMed ID: 29723366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.
    Hu SC; Lan CE
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29065479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis and the metabolic syndrome.
    Gisondi P; Fostini AC; Fossà I; Girolomoni G; Targher G
    Clin Dermatol; 2018; 36(1):21-28. PubMed ID: 29241748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities.
    Shlyankevich J; Mehta NN; Krueger JG; Strober B; Gudjonsson JE; Qureshi AA; Tebbey PW; Kimball AB
    Am J Med; 2014 Dec; 127(12):1148-53. PubMed ID: 25149424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis as a systemic disease.
    Grozdev I; Korman N; Tsankov N
    Clin Dermatol; 2014; 32(3):343-50. PubMed ID: 24767182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular and Metabolic Diseases Comorbid with Psoriasis: Beyond the Skin.
    Furue M; Tsuji G; Chiba T; Kadono T
    Intern Med; 2017; 56(13):1613-1619. PubMed ID: 28674347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Metabolic Syndrome in Chinese Patients With Erythrodermic Psoriasis: A Case-Control Study.
    Ma AR; Liu F; Wang R; Lin L; Wang Y; Li Q; Lu X; Du J
    Front Endocrinol (Lausanne); 2021; 12():677912. PubMed ID: 34970217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
    Ryan C; Kirby B
    Dermatol Clin; 2015 Jan; 33(1):41-55. PubMed ID: 25412782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic comorbidities and psoriasis.
    Gisondi P; Ferrazzi A; Girolomoni G
    Acta Dermatovenerol Croat; 2010; 18(4):297-304. PubMed ID: 21251450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities].
    Daudén E; Castañeda S; Suárez C; García-Campayo J; Blasco AJ; Aguilar MD; Ferrándiz C; Puig L; Sánchez-Carazo JL;
    Actas Dermosifiliogr; 2012 Jan; 103 Suppl 1():1-64. PubMed ID: 22364603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis and Metabolic Syndrome--scientific evidence and therapeutic implications.
    Voiculescu VM; Lupu M; Papagheorghe L; Giurcaneanu C; Micu E
    J Med Life; 2014; 7(4):468-71. PubMed ID: 25713604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriasis: classical and emerging comorbidities.
    Oliveira Mde F; Rocha Bde O; Duarte GV
    An Bras Dermatol; 2015; 90(1):9-20. PubMed ID: 25672294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catastrophic stroke burden in a patient with uncontrolled psoriasis and psoriatic arthritis: a case report.
    Fan JM; Solomon DA; López GY; Hofmann JW; Colorado RA; Kim AS; Meisel K; Halabi C
    BMC Neurol; 2020 Mar; 20(1):106. PubMed ID: 32199449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis and metabolic syndrome.
    Sales R; Torres T
    Acta Dermatovenerol Croat; 2014; 22(3):169-74. PubMed ID: 25230056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.